Sands Capital Ventures Discovery Fund III, L.P.

Insider Reports History

Entity
Company
Location
C/O Sands Capital Ventures, Llc, 1000 Wilson Boulevard, Suite 3000, Arlington, VA
Signature
/s/ Jonathan Goodman, General Counsel of Sands Capital Ventures Discovery Fund III-GP, LLC, the General Partner of Sands Capital Ventures Discovery Fund III, L.P.
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Sands Capital Ventures Discovery Fund III, L.P.:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Acumen Pharmaceuticals, Inc. 10%+ Owner Common Stock 3.42M $11.9M $3.47 Jul 6, 2021 Direct
Acumen Pharmaceuticals, Inc. 10%+ Owner Series A-1 Preferred Stock 0 Jul 6, 2021 Direct
Acumen Pharmaceuticals, Inc. 10%+ Owner Series B Preferred Stock 0 Jul 6, 2021 Direct

Insider Reports Filed by Sands Capital Ventures Discovery Fund III, L.P.

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ABOS Acumen Pharmaceuticals, Inc. Jul 6, 2021 5 $6.7M 4 Jul 8, 2021 10%+ Owner
ABOS Acumen Pharmaceuticals, Inc. Jun 30, 2021 0 $0 3 Jun 30, 2021 10%+ Owner